![]() |
Bladder Cancer |
Free Subscription
2 Aktuelle Urol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
[Bimodal and multimodal endoscopy of the urinary bladder in diagnosis and
treatment].
Aktuelle Urol. 2025;56:242-247.
PubMed
Abstract available
[mpMRI of the Urinary Bladder: Significance and Clinical Use].
Aktuelle Urol. 2025;56:248-257.
PubMed
Abstract available
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in
T2N0M0 Urothelial Bladder Cancer.
Ann Surg Oncol. 2025 May 27. doi: 10.1245/s10434-025-17488.
PubMed
Abstract available
ASO Author Reflections: Artificial Intelligence in Bladder Cancer-Transforming
Diagnosis and Treatment Paradigms.
Ann Surg Oncol. 2025 May 28. doi: 10.1245/s10434-025-17538.
PubMed
Randomized Study of Short-time Continuous Saline Irrigation After Transurethral
Resection in Non-muscle Invasive Bladder Cancer.
Anticancer Res. 2025;45:2653-2660.
PubMed
Abstract available
Efficacy of Pembrolizumab as Second or Third-line Therapy for Local Advanced and
Metastatic Urothelial Cancer.
Anticancer Res. 2025;45:2563-2573.
PubMed
Abstract available
Cytologic Assessment of the Supernatants of Formalin Solution Following
Histologic Examination of Transurethral Biopsy/Resection Specimens: Potential
Detection of Denuded Urothelial Cancer Cells.
Arch Pathol Lab Med. 2025;149:573-577.
PubMed
Abstract available
Analysis of IGFL2 Gene Expression and Prognostic Value in Bladder Cancer Based On
TCGA Database.
Asia Pac J Clin Oncol. 2025 May 29. doi: 10.1111/ajco.14191.
PubMed
Abstract available
The Effect of Surgeon Experience on the Recurrence of Non-Muscle Invasive Bladder
Cancer (NMIBC), Following Transurethral Resection of the Bladder Tumor (TURBT): A
double Blinded Prospective Randomized Study.
Asian Pac J Cancer Prev. 2025;26:1767-1771.
PubMed
Abstract available
Integration of Single-Cell and Bulk Transcriptome to Reveal an Endothelial
Transition Signature Predicting Bladder Cancer Prognosis.
Biology (Basel). 2025;14:486.
PubMed
Abstract available
Co-targeting the CD73-adenosinergic axis enhances the anti-tumor efficacy of
anti-PD-L1 immunotherapy in bladder cancer.
Biomed Pharmacother. 2025;188:118188.
PubMed
Abstract available
Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision
Medicine Approach.
Biomedicines. 2025;13:1145.
PubMed
Abstract available
Investigating the Genetic Links Between Immune Cell Profiles and Bladder Cancer:
A Multidisciplinary Bioinformatics Approach.
Biomedicines. 2025;13:1203.
PubMed
Abstract available
Impact of concomitant carcinoma in situ distribution on non-muscle-invasive
bladder cancer progression risk.
BJU Int. 2025 May 26. doi: 10.1111/bju.16793.
PubMed
Abstract available
Novel neoadjuvant therapies for muscle-invasive bladder cancer: Systematic review
and meta-analysis.
BJUI Compass. 2025;6:e70031.
PubMed
Abstract available
Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer
analysis.
BMC Cancer. 2025;25:932.
PubMed
Abstract available
Septicemia following sudden pituitary apoplexy after bladder tumor surgery: a
case report.
BMC Neurol. 2025;25:228.
PubMed
Abstract available
The role of tumor-infiltrating lymphocytes and depth of invasion in T1 bladder
cancer: a retrospective analysis.
BMC Urol. 2025;25:135.
PubMed
Abstract available
Infrapubic Foley catheter balloon tamponade for retropubic venous haemorrhage
during radical cystoprostatectomy and urethrectomy.
BMJ Case Rep. 2025;18:e265030.
PubMed
Abstract available
Metanephrine normal, DOTATATE negative paraganglioma of the urinary bladder.
BMJ Case Rep. 2025;18:e266048.
PubMed
Abstract available
Identification and Evaluation of the Urinary Microbiota Associated With Bladder
Cancer.
Cancer Innov. 2025;4:e70012.
PubMed
Abstract available
Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer:
comparison between patients from a Dutch nationwide cohort and KEYNOTE-045.
Cancer Treat Res Commun. 2025;43:100931.
PubMed
Abstract available
Active Surveillance in Non-Muscle Invasive Bladder Cancer: A Systematic Review.
Cancers (Basel). 2025;17:1714.
PubMed
Abstract available
The key regulator circPDE3B promotes arsenic-induced bladder carcinogenesis by
affecting STAT3 and NF-kappaB stability.
Cell Biol Toxicol. 2025;41:91.
PubMed
Abstract available
Safety and Efficacy of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and
Cisplatin with Pegfilgrastim in Japanese Patients with Advanced or Metastatic
Urothelial Carcinoma.
Chemotherapy. 2025;70:85-91.
PubMed
Abstract available
Association Between Rheumatoid Arthritis, Frailty Status, and Mortality in Older
Adults with Bladder Cancer.
Clin Genitourin Cancer. 2025 Apr 30:102369. doi: 10.1016/j.clgc.2025.102369.
PubMed
Abstract available
Diagnostic workout of glandular malignant lesions of the bladder according to the
5th WHO classification.
Crit Rev Clin Lab Sci. 2025;62:301-312.
PubMed
Abstract available
A Prospective Assessment of the Vesical Imaging Reporting and Data System in the
Diagnosis of Muscle-Invasive Bladder Cancer.
Cureus. 2025;17:e83068.
PubMed
Abstract available
Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial
Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for
Bladder Cancer Care and Research Symposium.
Curr Oncol. 2025;32:278.
PubMed
Abstract available
RETRACTION: Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances
Cell Proliferation, Migration, and Invasion in Bladder Cancer.
Dis Markers. 2025;2025:9803765.
PubMed
Abstract available
Bladder cancer biomarker analysis and drugtarget prediction based on
pyroptosis-related genes.
Discov Oncol. 2025;16:924.
PubMed
Abstract available
From exposure to innovation: decoding aromatic amines' role in bladder cancer
mechanisms.
Discov Oncol. 2025;16:888.
PubMed
Abstract available
HER2 prognostic values in non-muscle-invasive bladder cancer: a step towards
personalized treatment for BCG instillation.
Discov Oncol. 2025;16:891.
PubMed
Abstract available
Desmocollin-3 and Bladder Cancer.
Diseases. 2025;13:131.
PubMed
Abstract available
Role of Adjuvant Therapy in Current Perioperative Immunotherapy-based Trials in
Bladder Cancer: A Justified Standard.
Eur Urol Focus. 2025 May 23:S2405-4569(25)00121.
PubMed
Abstract available
The use of ctDNA for muscle-invasive bladder cancer before and after radical
cystectomy.
Expert Rev Anticancer Ther. 2025 May 26. doi: 10.1080/14737140.2025.2512036.
PubMed
Abstract available
A lactate-related tSNE signature defines prognostic subtypes of bladder cancer
and reveals LINC01094-mediated VIM stabilization in metastasis and drug
resistance.
Front Immunol. 2025;16:1593523.
PubMed
Abstract available
Antibody-drug conjugates as game changers in bladder cancer: current progress and
future directions.
Front Immunol. 2025;16:1591191.
PubMed
Abstract available
Elevated platelet-to-lymphocyte ratio predicts poor clinical outcomes in
non-muscle invasive bladder cancer: a systematic review and meta-analysis.
Front Immunol. 2025;16:1578069.
PubMed
Abstract available
Uncovering citron kinase as a key biomarker for predicting outcomes and therapy
efficacy in non-muscle-invasive bladder cancer.
Gene. 2025 May 21:149590. doi: 10.1016/j.gene.2025.149590.
PubMed
Abstract available
Plasmacytoid urothelial carcinoma of the urinary bladder: A single institution
experience with focus on next-generation sequencing (NGS) and PD-L1
immunohistochemistry.
Hum Pathol. 2025;158:105788.
PubMed
Abstract available
NEURL1 acts as a candidate suppressor in bladder cancer by down-regulating PDE9A.
In Vitro Cell Dev Biol Anim. 2025 May 29. doi: 10.1007/s11626-025-01047.
PubMed
Abstract available
miR-944 inhibits malignant progression of bladder cancer through ATIC/AKT/FOXO3 A
axis mediated by SHMT1.
In Vitro Cell Dev Biol Anim. 2025 May 29. doi: 10.1007/s11626-025-01050.
PubMed
Abstract available
Proteome-driven transcriptomic dissection of EMT networks in bladder cancer based
on the VIM and CDH2 protein macromolecules influence: From molecular-protein
subtyping to therapeutic target prioritization.
Int J Biol Macromol. 2025;315.
PubMed
Abstract available
Glycomics and Glycoproteomics Reveal Distinct Oligomannose Carriers Across
Bladder Cancer Stages.
Int J Mol Sci. 2025;26:4891.
PubMed
Abstract available
Correction: Sturm et al. Exposure of Bladder Cancer Cells to Blue Light (lambda = 453
nm) in the Presence of Riboflavin Synergistically Enhances the Cytotoxic
Efficiency of Gemcitabine. Int. J. Mol. Sci. 2024, 25, 4868.
Int J Mol Sci. 2025;26:4790.
PubMed
Abstract available
Engineered Salmonella Carrying siRNA-PD-1 Shrinks orthotopically implanted
Bladder Cancer in Rats.
J Drug Target. 2025 May 26:1-12. doi: 10.1080/1061186X.2025.2512619.
PubMed
Abstract available
Microsatellite instability and mismatch repair deficiency in bladder urothelial
carcinoma: a Tunisian single-center study.
J Egypt Natl Canc Inst. 2025;37:22.
PubMed
Abstract available
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder
cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.
J Immunother Cancer. 2025;13:e012045.
PubMed
Abstract available
A meta-analytic appraisal of robotic-assisted cystectomy outcomes in the elderly
octogenarian population.
J Robot Surg. 2025;19:232.
PubMed
Abstract available
Sex-specific gut microbiota and neutrophil senescence in bladder cancer.
Nat Cancer. 2025;6:738.
PubMed
CD56 on intratumoral NK cells: orchestrating NK cell-mediated anti-tumor effects
in bladder cancer.
Neoplasia. 2025;66:101187.
PubMed
Abstract available
Nucleosides Nucleotides Nucleic Acids
Prognostic significance of copper metabolism-related genes as risk markers in
bladder urothelial carcinoma.
Nucleosides Nucleotides Nucleic Acids. 2025;44:598-616.
PubMed
Abstract available
Crosstalk between SUMOylation and ubiquitination controls the stability of
transcription factor zinc finger protein 24: a novel antitumor mechanism in
bladder cancer.
Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03450.
PubMed
Abstract available
Efficacy and safety of BCG and immune checkpoint inhibitors in non-muscle
invasive bladder cancer: A meta-analysis with exploratory chemotherapy
comparisons.
Oncol Lett. 2025;30:348.
PubMed
Abstract available
AMIGO2 expression at the invasive front of bladder cancer predicts
recurrence-free and overall survival after radical cystectomy.
Oncol Lett. 2025;30:339.
PubMed
Abstract available
Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of
Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients.
Pharmaceuticals (Basel). 2025;18:701.
PubMed
Abstract available
Combining Radiotherapy with Immune Checkpoint Inhibitors for the Management of
Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review from the Y-ECI
ROSC EORTC group.
Pract Radiat Oncol. 2025 May 22:S1879-8500(25)00147.
PubMed
Abstract available
Urological cancer risk in patients with rheumatoid arthritis compared to matched
controls: a nationwide cohort study.
Rheumatology (Oxford). 2025;64:3458-3467.
PubMed
Abstract available
Bladder lesion detection using EfficientNet and hybrid attention transformer
through attention transformation.
Sci Rep. 2025;15:18042.
PubMed
Abstract available
Association of different treatment modalities for rectal cancer and second
primary urinary system neoplasms, findings from SEER.
Sci Rep. 2025;15:18782.
PubMed
Abstract available
Impact of pelvic lymph node dissection on survival outcomes in non-muscle
invasive bladder cancer: a multicenter retrospective study.
Sci Rep. 2025;15:18905.
PubMed
Abstract available
Disulfide bond-related gene signature development for bladder cancer prognosis
prediction and immune microenvironment characterization.
Sci Rep. 2025;15:18826.
PubMed
Abstract available
Molecular mechanistic approach to reveal decitabine's effect on DNMT gene
modulation and its inhibitory role in heavy metal-induced proliferation in
urinary bladder cancer cell line.
Toxicol In Vitro. 2025 May 23:106082. doi: 10.1016/j.tiv.2025.106082.
PubMed
Abstract available
Associations of a claims-based frailty index with perioperative outcomes and
survival among older adults undergoing radical cystectomy for bladder cancer.
Urol Oncol. 2025 May 27:S1078-1439(25)00168.
PubMed
Abstract available
What motivates bladder cancer patients to be active? A qualitative study
assessing attitudes towards physical activity and digital health technologies.
Urol Oncol. 2025 May 28:S1078-1439(25)00176.
PubMed
Abstract available
Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guerin
(BCG)-unresponsive non-muscle-invasive bladder cancer.
Urol Oncol. 2025 May 24:S1078-1439(25)00134.
PubMed
Abstract available
Prognostic role of pathological substaging in high-grade pT1 bladder cancer
undergoing BCG therapy: Insights on recurrence and progression.
Urol Oncol. 2025 May 23:S1078-1439(25)00174.
PubMed
Abstract available
Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial
carcinoma of the bladder? The end of the "jump" of the lamina propria layer myth.
World J Urol. 2025;43:324.
PubMed
Abstract available
Does having an asymptomatic renal stone increase morbidity after radical
cystectomy?
World J Urol. 2025;43:336.
PubMed
Abstract available
Thank you for your interest in scientific medicine.